Related references
Note: Only part of the references are listed.Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
Floris Dammeijer et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
Michael A. Cannarile et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
Muhammad Baghdadi et al.
CANCER RESEARCH (2016)
Functions of interleukin-34 and its emerging association with rheumatoid arthritis
Ren-Peng Zhou et al.
IMMUNOLOGY (2016)
CSF1 is involved in breast cancer progression through inducing monocyte differentiation and homing
Jingxian Ding et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Growth rate of vestibular schwannoma
Iddo Paldor et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma
Liu Yang et al.
BMC CANCER (2015)
IL-34 and M-CSF form a novel heteromeric cytokine and regulate the M-CSF receptor activation and localization
Aude I. Segaliny et al.
CYTOKINE (2015)
Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma
Zuzanna Baranski et al.
JOURNAL OF PATHOLOGY (2015)
Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment
Aude I. Segaliny et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
IL-34 and CSF-1: similarities and differences
Yuko Nakamichi et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2013)
Tumor-Associated Macrophages Are Related to Volumetric Growth of Vestibular Schwannomas
Maurits de Vries et al.
OTOLOGY & NEUROTOLOGY (2013)
Epidemiology and Natural History of Vestibular Schwannomas
Sven-Eric Stangerup et al.
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA (2012)
Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas
Maurits de Vries et al.
VIRCHOWS ARCHIV (2012)
Macrophages at the Fetal-Maternal Interface Express Markers of Alternative Activation and Are Induced by M-CSF and IL-10
Judit Svensson et al.
JOURNAL OF IMMUNOLOGY (2011)
Jekyll and Hyde: the role of the microenvironment on the progression of cancer
Michael Allen et al.
JOURNAL OF PATHOLOGY (2011)
Anti-Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors
Hon Kit Wong et al.
CANCER RESEARCH (2010)
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
Victor-Felix Mautner et al.
NEURO-ONCOLOGY (2010)
True Incidence of Vestibular Schwannoma?
Sven-Eric Stangerup et al.
NEUROSURGERY (2010)
Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients
Scott R. Plotkin et al.
OTOLOGY & NEUROTOLOGY (2010)
Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation
G. Solinas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors
Kyoko Kawamura et al.
PATHOLOGY INTERNATIONAL (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Discovery of a cytokine and its receptor by functional screening of the extracellular proteome
Haishan Lin et al.
SCIENCE (2008)
Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis
HM Kluger et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
